Abbott Laboratories (LON:0Q15)

Market Cap	145.06B -19.1%
Revenue (ttm)	32.94B +5.7%
Net Income	4.85B -51.3%
EPS	2.76 -51.3%
Shares Out	n/a
PE Ratio	29.93
Forward PE	19.64
Dividend	1.80 (1.60%)
Ex-Dividend Date	Jan 15, 2026

Volume	1,590
Average Volume	10,107
Open	113.45
Previous Close	113.03
Day's Range	111.00 - 113.45
52-Week Range	105.36 - 141.41
Beta	0.75
RSI	44.57
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2025, Abbott Laboratories's revenue was $44.33 billion, an increase of 5.67% compared to the previous year's $41.95 billion. Earnings were $6.52 billion, a decrease of -51.13%.

Financial numbers in USD